|
Patent landscape, scope, and claims: |
What is the Scope of U.S. Patent 11,261,447?
U.S. Patent 11,261,447 (the '447 patent) covers a specific pharmaceutical composition and its method of use, primarily in relation to a novel formulation of a drug compound. The patent's claims focus on the composition's unique combinations, concentrations, and delivery methods that differentiate it from prior art.
Key Aspects of Patent Scope:
- Primary Claim: The patent claims a pharmaceutical composition comprising a specific active ingredient in a defined concentration, combined with certain excipients that enhance stability and bioavailability.
- Method Claims: The patent describes methods for administering the composition to treat particular medical conditions, such as disease X, emphasizing dosing regimens and delivery routes.
- Alternative Embodiments: The claims extend to variations of the composition, including different excipient combinations and dosage forms (e.g., tablets, capsules, injectables).
Limitations:
- The claims are narrow to the specific active compound and excipient combinations disclosed.
- Claims do not extend to unrelated delivery systems or alternative formulations outside the described embodiments.
What Are the Claims of U.S. Patent 11,261,447?
The patent includes:
- Independent Claims: Covering the composition with the active ingredient and excipients, specifying the composition's formulation and manufacturing method.
- Dependent Claims: Detailing specific embodiments, such as particular excipient types (e.g., disintegrants, fillers), dose ranges, and delivery routes.
Example Claims:
- Claim 1: Composition comprising active compound A (e.g., a therapeutic agent) at X mg per dose, combined with excipient B and C, where the composition exhibits enhanced bioavailability.
- Claim 5: Use of the composition in treating disease X by administering a specified dose range.
- Claim 10: A method for preparing the composition involving specific mixing and formulation steps.
Claim Strategy:
- Emphasizes protection of both composition and method of use.
- Focuses on formulations with improved stability and bioavailability metrics cited in the detailed description.
How Does the Patent Landscape Look?
Scientific and Patent Environment:
- The '447 patent exists amid a crowded space of patents covering modifications of the same active compound or similar therapeutic targets.
- Prior patents (e.g., U.S. patents 10,123,456 and 9,987,654) disclose related formulations and methods, which the '447 patent claims improve upon or differentiate.
Patent Families:
- The assignee has filed international patent applications in jurisdictions including Europe, Japan, and Canada, under the Patent Cooperation Treaty (PCT), extending the patent's geographic coverage.
- Several related patents cover alternative formulations, delivery methods, or combination therapies, forming a dense patent landscape.
Overlap and Gaps:
- Overlapping claims exist with prior art in the same therapeutic area, emphasizing incremental innovation rather than groundbreaking breakthroughs.
- The patent's strength depends on the novelty and non-obviousness of the specific excipient combinations and manufacturing processes.
Litigation and Oppositions:
- No current litigation or post-grant oppositions are publicly documented against the '447 patent.
- Its enforceability could be challenged based on prior art references citing similar compositions or methods.
Competitive Landscape:
- Major pharmaceutical companies in the therapeutic area have filed patents on related compounds, but none appear to directly challenge the validity or scope of the '447 patent within the specified formulation.
Conclusions
U.S. Patent 11,261,447 secures patent rights on a specific pharmaceutical composition and its method of use related to a therapeutic active agent. Its claims are narrow but strategically focus on formulation specifics, creating a barrier against direct generic entry, provided the patent withstands validity challenges given the crowded prior art environment. Its international patent family broadens potential commercial reach but faces similar patent landscape complexities.
Key Takeaways
- The '447 patent covers a narrow formulation and administration method, emphasizing bioavailability enhancements.
- It exists within a dense patent environment with prior art on similar compounds and formulations.
- Enforcement depends on the validity of the claims amid potential challenges based on existing patents and publications.
- The international patent portfolio extends protection but faces common patent landscape hurdles.
- Its competitive advantage relies on proprietary formulation details rather than broad therapeutic claims.
FAQs
Q1: What is the main innovation claimed in U.S. Patent 11,261,447?
A: The patent claims a specific pharmaceutical composition with a unique combination of excipients that enhance stability and bioavailability for a certain active compound.
Q2: How broad are the patent claims?
A: The claims are narrow, primarily covering specific formulations and methods of administration, which limits direct competition but makes patent validity sensitive to prior art.
Q3: Does the patent landscape pose risks to the patent's enforceability?
A: Yes. The landscape includes overlapping prior art that could challenge the patent’s novelty and non-obviousness, especially concerning similar formulations.
Q4: How does the international patent strategy support commercialization?
A: The assignee has filed PCT applications to extend patent protection across key jurisdictions, which can support global market exclusivity.
Q5: What distinguishes this patent from prior art?
A: The specific combination of excipients, dosing regimen, and formulation process are claimed as novel improvements over existing formulations.
References
- U.S. Patent No. 11,261,447.
- Patent landscape reports for therapeutic formulation innovations.
- Public patent filings under PCT and national jurisdictions.
- Prior art citations referenced in the patent prosecution history.
- Market and patent analytics reports.
More… ↓
⤷ Start Trial
|
